Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Globe Newswire
Cytek Biosciences Ships 100th Advanced Flow Cytometry System
December 20, 2018 -
Business Wire
Compass Therapeutics Expands Leadership Team with Appointments of Chief Medical Officer and Chief Financial Officer
December 19, 2018 -
Business Wire
Semma Therapeutics Expands Executive Leadership Team
December 18, 2018 -
Carestack
CareStack® Announces Partnership with DentalXChange to Help Dental Practices Speed Claims Processing and Enhance Administrative Workflows
December 17, 2018 -
PRNewswire
Devoted Health Expands Provider Network With Top Hospitals in Lakeland Area
December 17, 2018 -
PRNewswire
Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China
December 16, 2018 -
Business Insider
VitalWare™ Introduces HospitalPriceIndex.com In Response To Governmental Pricing Transparency Mandate
December 14, 2018 -
B3C Newswire
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
December 14, 2018 -
Nasdaq
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
December 13, 2018 -
Business Wire
Caribou Biosciences Appoints Dr. Natalie Sacks to Board of Directors
December 12, 2018 -
Business Wire
Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing
December 12, 2018 -
PRNewswire
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints
December 12, 2018 -
Globe Newswire
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
December 10, 2018 -
Market Screener
Genomics plc Announces second close of Series B financing, raising a further £8m, bringing the total round to £33m
December 10, 2018 -
Globe Newswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease
December 10, 2018 -
Business Wire
Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space
December 6, 2018 -
Globe Newswire
Unum Therapeutics Inc. (UMRX) Secures U.S. Patent for ACTR Technology
December 6, 2018 -
Globe Newswire
Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting
December 5, 2018 -
Biospace
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101
December 5, 2018 -
Business Wire
Turnstone Biologics Unveils Novel Vaccinia Oncolytic Viral Immunotherapy Platform
November 30, 2018 -
BC Extra
Chi-Med, Innovent Enter Global Cancer Partnership
November 30, 2018 -
PRNewswire
Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors
November 29, 2018 -
Business Wire
Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy
November 27, 2018 -
PRNewswire
Blue Cross Blue Shield of Massachusetts Expands Medicare Network to Include Iora Health
November 20, 2018 -
PRNewswire
TraceLink Achieves 55% Overall Revenue Growth for Q3 2018
November 19, 2018 -
PRNewswire
Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
November 16, 2018 -
CareStack® Partners with Callpop to Expand Patient Communication Capabilities for Dental Practices Nationwide
November 14, 2018 -
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
November 14, 2018 -
PRNewswire
Zeel Partners With Stride Health To Bridge Insurance Gap For Massage Therapists
November 14, 2018 -
Globe Newswire
Cytek Biosciences Continues Momentum by Strengthening Executive Team, Adding Board Members
November 13, 2018 -
Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist
November 13, 2018 -
Modis Therapeutics Announces Prime Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency
November 13, 2018 -
PRNewswire
NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab)
November 12, 2018 -
Globe Newswire
Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium
November 9, 2018 -
Innovent Highlights Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC
November 9, 2018 -
B3C Newswire
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
November 8, 2018 -
PRNewswire
Maine’s Northern Light Beacon Health Partners with PatientPing to Coordinate Care for Patients Throughout the State — and Beyond
November 6, 2018 -
Globe Newswire
Unum Therapeutics to Present Preclinical Data on a New, Emerging Platform Technology for Solid Tumors at the SITC Annual Meeting
November 6, 2018 -
Business Wire
Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives
November 6, 2018 -
Business Wire
Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives
November 6, 2018 -
Business Wire
Compass Therapeutics Announces Preclinical Data on Lead Antibody Program and NK Cell Engager Platform to be Presented at the Society for Immunotherapy of Cancer Annual Meeting
November 6, 2018 -
B3C Newswire
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option
November 5, 2018 -
Globe Newswire
Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases
November 1, 2018 -
PRNewswire
PatientPing Expands Care Coordination Offering to Help Organizations Succeed Under BPCI Advanced
November 1, 2018 -
Reuters
China’s Innovent Biologics Makes 5 Percent Gain in Hong Kong Debut
October 31, 2018 -
PRNewswire
Adagene Announces First Patient Dosed in United States and Acceptance of IND in China for ADG-106
October 31, 2018 -
Globe Newswire
Orchard Therapeutics Announces Pricing of Initial Public Offering
October 30, 2018 -
Innovent Biologics Raises $421 Million in Hong Kong IPO
October 25, 2018 -
Globe Newswire
Cytek Biosciences Debuts Advanced Flow Cytometry System that Breaks the Cost Barrier
October 23, 2018 -
Business Wire
Kyruus Announces Launch of ProviderMatch for Salesforce on the Salesforce AppExchange to Help Health Systems Deliver Optimal Access Experience
October 23, 2018 -
Gene therapy biotech Orchard Therapeutics sets terms for $200 million IPO
October 23, 2018 -
PRNewswire
US HealthVest is Developing a New Behavioral Hospital on Hendricks Regional Health Plainfield Campus
October 17, 2018 -
Devoted Health, New Medicare Advantage Business, Raises $300 Million
October 16, 2018 -
PRNewswire
TraceLink Announces Availability of End-to-End DSCSA Saleable Returns Verification Solution for Pharmaceutical Manufacturers and Wholesale Distributors
October 16, 2018 -
PRNewswire
PatientPing’s National Community of ACO Providers Generate More than $270 Million in Shared Savings
October 10, 2018 -
Business Wire
Buoy Health Named to CNBC’s 2018 Upstart 100 List Highlighting Innovation and Rapid Growth
October 9, 2018 -
PRNewswire
FAREVA Selects TraceLink to Comply with EU FMD Regulations
October 8, 2018 -
Orchard Therapeutics plans $172.5 million U.S. IPO
October 5, 2018 -
Business Wire
Buoy Health Receives Robert Wood Johnson Foundation Artificial Intelligence Award for Patient Health Education
October 3, 2018 -
TraceLink Surpasses 1,000 Customer Milestone, Including Over 500 Pharmaceutical Manufacturing Companies
October 3, 2018 -
Centogene, Denali Therapeutics Partner to Recruit Parkinson’s Patients for Drug Program
October 3, 2018 -
FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company
October 2, 2018 -
Notable Health Named an IDC Innovator for Enterprise Wearable Software Solutions in Health Care
October 1, 2018 -
Modis Therapeutics Announces $30M Series A Financing
October 1, 2018 -
Pharmeasy raises $50 million in Series C funding
September 29, 2018 -
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188
September 29, 2018 -
Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture
September 27, 2018 -
NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer
September 24, 2018 -
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Previously Treated Non-Small Cell Lung Cancer at Annual Meeting of the Chinese Society of Clinical Oncology
September 21, 2018 -
b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System
September 21, 2018 -
CareStack™ Announces Completion of $16 Million Financing to Expand Cloud-Based Enterprise Platform for Dental Practices
September 21, 2018 -
Devoted Health Receives License from State of Florida
September 20, 2018 -
Hua Medicine Successfully Completes Initial Public Offering and Listing on the Hong Kong Stock Exchange
September 14, 2018 -
Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Improved Care in Arizona, Georgia and Washington
September 13, 2018 -
Innovent doses first patient in Phase III sintilimab trial for NSCLC
September 13, 2018 -
Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
September 12, 2018 -
Unum Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference
September 10, 2018 -
Innovent’s Anti-CD47 Antibody IBI188 Receives IND Approval in China
September 10, 2018 -
Notable Health Closes $13.5 Million Series A Financing to Expand Artificial Intelligence Powered Physician-Patient Interaction Platform
September 6, 2018 -
Tempest Therapeutics Names Dr. Ginna Laport CMO
September 5, 2018 -
Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate Combination Therapy with CMP-001 and Avelumab
September 5, 2018 -
Precision BioSciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics
September 5, 2018 -
Turnstone Biologics and the La Jolla Institute for Allergy and Immunology Enter into Strategic Collaboration for Personalized Neoantigen Immunotherapies
September 4, 2018 -
Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
September 4, 2018 -
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
August 29, 2018 -
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
August 29, 2018 -
Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources
August 29, 2018 -
TraceLink, which helps pharma companies trace drugs through the supply chain, just raised $93 million
August 23, 2018 -
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
August 13, 2018 -
Buoy Health Partners With Boston Children’s Hospital To Improve The Way Parents Currently Assess Their Children’s Symptoms Online
August 10, 2018
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.